Very Low Single-Dose Quetiapine-Induced Myoclonus

Prim Care Companion CNS Disord. 2022 Jun 9;24(3):21cr02907. doi: 10.4088/PCC.21cr02907.

Authors

N A Uvais^{1

2}, A M Ashfaq³

Affiliations

¹ Department of Psychiatry, Iqraa International Hospital and Research Centre, Calicut, Kerala, India.
² Corresponding author: N. A. Uvais, MMBS, DPM, Iqraa International Hospital and Research Centre, Calicut, Kerala, India (druvaisna@gmail.com).
³ Department of Psychiatry, Calicut Medical College, Calicut, Kerala, India.

PMID: 35687883
DOI: 10.4088/PCC.21cr02907

No abstract available

© Copyright 2022 Physicians Postgraduate Press, Inc.

MeSH terms

Antipsychotic Agents* / adverse effects
Dose-Response Relationship, Drug
Humans
Myoclonus* / chemically induced
Quetiapine Fumarate / adverse effects

Substances

Antipsychotic Agents
Quetiapine Fumarate